CLINICAL_TRIALS
trial_result
· 2020-03-18
Clinical Trial Update: Efficacy and Safety of Anifrolumab Compared to Placebo in Adult Subjects With Active Systemic Lupus Erythematosus [Phase 3]
Summary
Phase 3 trial updating efficacy and safety of anifrolumab versus placebo in adults with active systemic lupus erythematosus. Results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: AstraZeneca | Conditions: Active Systemic Lupus Erythematosus | Phase 3 | Status: COMPLETED | Results posted: 2020-03-18